Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Zilembo

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Cancer Treatment Reviews|July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trendsE Bajetta, N Zilembo, A Di Leo, et al.
Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.
Critical Reviews in Oncology/Hematology|December 31, 2013
Targeted therapy-induced diarrhea: A review of the literatureM A Pessi, N Zilembo, E R Haspinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsE Bajetta, N Zilembo, E Bichisao, et al.
Cancer|January 15, 1996
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology GroupM di Bartolomeo, E Bajetta, R Buzzoni, et al.
Tumori|December 31, 1994
Formestane as treatment of advanced breast cancer in elderly womenN Zilembo, R Buzzoni, L Celio, et al.
Tumori|February 28, 1994
Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancerE Bajetta, L Celio, N Zilembo, et al.
Cancer|August 22, 2000
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trialE Bajetta, S Chiara Stani, D De Candis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestaneA Martinetti, E Bajetta, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Cancer Treatment Reviews|July 1, 1994
Hormone therapy in advanced breast carcinoma: present and future trendsE Bajetta, N Zilembo, A Di Leo, et al.
Oncology|November 1, 1995
Activity of formestane in de novo tamoxifen-resistant patients with metastatic breast cancerC Noberasco, E Bajetta, N Zilembo, et al.
Critical Reviews in Oncology/Hematology|December 31, 2013
Targeted therapy-induced diarrhea: A review of the literatureM A Pessi, N Zilembo, E R Haspinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitorsE Bajetta, N Zilembo, E Bichisao, et al.
Cancer|January 15, 1996
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology GroupM di Bartolomeo, E Bajetta, R Buzzoni, et al.
Tumori|December 31, 1994
Formestane as treatment of advanced breast cancer in elderly womenN Zilembo, R Buzzoni, L Celio, et al.
Tumori|February 28, 1994
Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancerE Bajetta, L Celio, N Zilembo, et al.
Cancer|August 22, 2000
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trialE Bajetta, S Chiara Stani, D De Candis, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1997
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestaneA Martinetti, E Bajetta, E Seregni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2013
Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trialG Procopio, E Verzoni, S Bracarda, et al.
Pageof 6